A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls;Vergleich der hepatischen Transitzeit (HTT) verschiedener Ultraschallkontrastmittel (USKM) bei Patienten mit Lebermetastasen und gesunden Probanden

Ultraschall in der Medizin

Volumn 31, Issue 6, 2010, Pages 582-588

  Haendl, T ^a   Strobel, D ^a   Neureiter, D ^b   Esser, K ^a   Frieser, M ^a   Hahn, E G ^a   Bernatik, T ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Paracelsus Medizinische Privatuniversität ^*  (Germany)

Author keywords

Contrast enhanced ultrasound; Hepatic transit time; Liver metastases

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUTREN; PHOSPHOLIPID; POLYSACCHARIDE; SHU 508; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER TUMOR; MALE; METABOLIC CLEARANCE RATE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE;

ADULT; AGED; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PHOSPHOLIPIDS; POLYSACCHARIDES; REFERENCE VALUES; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 78649369261     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0028-1109953     Document Type: Article

References (29)

1. Blyth S, Blakeborough A, Peterson M et al. Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases. Ann R Coll Surg Engl 2008 90 25-28
2. Nomura K, Kadoya M, Ueda K et al. Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging. JClin Gastroenterol 2007 41 789-795
3. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007 33 1515-1526
4. Young N, Sing T, Wong K P. et al. Use of spiral and non-spiral computed tomography arterial portography in the detection of potentially malignant liver masses. JGastroenterol Hepatol 1997 12 385-391
5. Robinson P J. Imaging liver metastases: current limitations and future prospects. Br J Radiol 2000 73 234-241
6. Leen E. The detection of occult liver metastases of colorectal carcinoma. JHepatobiliary Pancreat Surg 1999 6 7-15
7. Leveson S H., Wiggins P A., Giles G R. et al. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg 1985 72 128-130
8. Leen E, Goldberg J A., Anderson J R. et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993 34 554-557
9. Leen E, Goldberg J A., Angerson W J. et al. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000 355 34-37 (Pubitemid 30072181)
10. Fowler R C., Harris K M., Swift S E. et al. Hepatic Doppler perfusion index: measurement in nine healthy volunteers. Radiology 1998 209 867-871
11. Bernatik T, Becker D, Neureiter D et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004 16 313-317
12. Albrecht T, Blomley M J., Cosgrove D O. et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999 353 1579-1583
13. Albrecht T, Blomley M J., Cosgrove D O. et al. Transit-time studies with levovist in patients with and without hepatic cirrhosis: a promising new diagnostic tool. Eur Radiol 1999 9 Suppl 3 S377-381
14. Bernatik T, Strobel D, Hausler J et al. Hepatic transit time of an ultrasound echo enhancer indicating the presence of liver metastases first clinical results. Ultraschall in Med 2002 23 91-95
15. Albrecht T H., Hohmann J. Up-date on transit time analysis of the liver. 12th European symposium on contrast enhanced ultrasound imaging,. Rotterdam The Netherlands 25 25 January 2007 27-29
16. Haendl T, Strobel D, Steinebrunner N et al. Hepatic transit time in benign liver lesions. Ultraschall in Med 2008 29 184-189
17. Hohmann J, Muller C, Oldenburg A et al. Hepatic transit time analysis using contrast-enhanced ultrasound with BR 1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol 2009 35 1427-1435
18. Strobel D, Seitz K, Blank W et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall in Med 2009 30 376-382
19. Seitz K, Strobel D, Bernatik T et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall in Med 2009 30 383-389
20. Konopke R, Bunk A, Kersting S. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall in Med 2008 29 S203-S209
21. Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) update 2008. Ultraschall in Med 2008 29 28-44
22. Bang N, Nielsen M B., Rasmussen A N. et al. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001 74 752-755
23. Lim A K., Taylor-Robinson S D., Patel N et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005 54 128-133
24. Hohmann J, Skrok J, Puls R et al. Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue. Rntgenstr Fortschr 2003 175 835-843
25. Lim A K., Patel N, Eckersley R J. et al. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006 240 130-135
26. Bauer A, Blomley M, Leen E et al. Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 1999 9 S349-S352
27. Lim A K., Patel N, Eckersley R J. et al. Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology 2004 231 785-788
28. Yanagisawa K, Moriyasu F, Miyahara T et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007 33 318-325
29. Kruskal J B., Thomas P, Kane R A. et al. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004 231 482-490